Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells.
作者： Y Nakano , S Tanno , K Koizumi , T Nishikawa , K Nakamura
关键词:
摘要: To identify predictive molecular markers for gemcitabine resistance, we investigated changes in the expression of four genes associated with gemcitabine transport and …
nature.com
researchgate.net 
sci-hub.se 参考文章(30)
Clasina L. van der Wilt, Judith R. Kroep, Andries M. Bergman, Willem J.P. Loves, Enrique Alvarez, Iannnis Talianidis, Staffan Eriksson, Cees J. van Groeningen, Herbert M. Pinedo, Godefridus J. Peters, The role of deoxycytidine kinase in gemcitabine cytotoxicity. Advances in Experimental Medicine and Biology. ,vol. 486, pp. 287- 290 ,(2002) , 10.1007/0-306-46843-3_56
Yun Yen, Shu Mi, Edward Hu, Yih Gang Goan, Bingsen Zhou, Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line. Cancer Research. ,vol. 59, pp. 4204- 4207 ,(1999)
Gary K. Schwartz, Christoph P. Jung, Monica V. Motwani, Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit. Clinical Cancer Research. ,vol. 7, pp. 2527- 2536 ,(2001)
David W. Hedley, Patricia S. Firby, David R. Rauchwerger, Malcolm J. Moore, Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity. Cancer Research. ,vol. 60, pp. 6075- 6079 ,(2000)
J. B. Vermorken, S. Eriksson, G. J. Peters, E. Boven, A. P. A. Stegmann, Gijsbert Veerman, V. W. T. Ruiz Van Haperen, M. Hermsen, H. M. Pinedo, Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780 Cancer Research. ,vol. 54, pp. 4138- 4143 ,(1994)
Carlos Galmarini, Marilyn L Clarke, Lars Jordheim, Cheryl L Santos, Emeline Cros, John R Mackey, Charles Dumontet, Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene BMC Pharmacology. ,vol. 4, pp. 8- 8 ,(2004) , 10.1186/1471-2210-4-8
H A Burris, M J Moore, J Andersen, M R Green, M L Rothenberg, M R Modiano, M C Cripps, R K Portenoy, A M Storniolo, P Tarassoff, R Nelson, F A Dorr, C D Stephens, D D Von Hoff, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of Clinical Oncology. ,vol. 15, pp. 2403- 2413 ,(1997) , 10.1200/JCO.1997.15.6.2403
H. Fan, C. Villegas, J. A. Wright, Ribonucleotide Reductase R2 Component is a Novel Malignancy Determinant that Cooperates with Activated Oncogenes to Determine Transformation and Malignant Potential Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 14036- 14040 ,(1996) , 10.1073/PNAS.93.24.14036
J. R. Mackey, S. Y. M. Yao, K. M. Smith, E. Karpinski, S. A. Baldwin, C. E. Cass, J. D. Young, Gemcitabine Transport in Xenopus Oocytes Expressing Recombinant Plasma Membrane Mammalian Nucleoside Transporters Journal of the National Cancer Institute. ,vol. 91, pp. 1876- 1881 ,(1999) , 10.1093/JNCI/91.21.1876
Banke Agarwal, Emad Abu-Hamda, Kimber L. Molke, Arlene M. Correa, Linus Ho, Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. The American Journal of Gastroenterology. ,vol. 99, pp. 844- 850 ,(2004) , 10.1111/J.1572-0241.2004.04177.X